❌

Normal view

NEC invests in US-based robotics startup Dexmate

25 August 2026 at 10:43
Japanese technology giant NEC’s corporate venture capital fund has invested in US-based robotics startup Dexmate, developer of the VEGA humanoid robot and an integrated physical AI development platform. The investment was made through the NEC Orchestrating Future Fund (NOFF), with NEC and Dexmate planning to explore opportunities to deploy physical AI technologies across a range […]

Travere Therapeutics Turns a Rare Disease Approval into Two Quarters of Accelerating Sales

22 August 2026 at 12:48
The Food and Drug Administration granted Travere Therapeutics full approval for FILSPARI in focal segmental glomerulosclerosis on April 13, 2026, the drug’s second full approval after a 2023 clearance for IgA nephropathy. Travere’s stock rose 43 percent the next day, closing at $43.81.Β  The DUPLEX Data Behind a Second Approval FSGS damages the kidney’s filtering […]

FORT Robotics to go public via business combination with Newbury Street II Acquisition Corp

18 August 2026 at 14:29
FORT Robotics, a safety platform developing a β€œtrust layer” for physical AI, and Newbury Street II Acquisition Corp, a special purpose acquisition company, have entered into a definitive business combination agreement that will result in the combined company becoming a publicly traded company. Upon closing of the business combination, the combined company will be named […]

Unitree IPO oversubscribed more than 5,000 times as investors pile into humanoid robotics

14 August 2026 at 11:09
Unitree Robotics’ initial public offering has reportedly been oversubscribed more than 5,000 times as investors scramble for shares in one of China’s best-known humanoid robot manufacturers. The Hangzhou-based company priced its IPO at 150.8 yuan ($22.4) per share, raising approximately $900 million and giving Unitree a valuation of around $9 billion, according to CNBC. Demand […]
❌